Research Topics

Oliver Husser



  1. Rheude T, Blumenstein J, Mollmann H, Husser O. Spotlight on the SAPIEN 3 transcatheter heart valve. Med Devices (Auckl). 2018;11:353-360 pubmed publisher
    ..In this review, the Edwards SAPIEN 3 THV is discussed in terms of technology, procedural advances and complication trends and future developments. ..
  2. Husser O, Fujita B, Hengstenberg C, Frerker C, Beckmann A, Möllmann H, et al. Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry. JACC Cardiovasc Interv. 2018;11:567-578 pubmed publisher
    ..15.5%; HR: 0.90; 95% CI: 0.78 to 1.03; p = 0.130) were observed. Use of LACS in transcatheter aortic valve replacement is safe, with fewer post-procedural complications and lower early mortality, suggesting its broad application. ..
  3. Trenkwalder T, Pellegrini C, Holzamer A, Rheude T, Riester J, Reinhard W, et al. Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction. Clin Res Cardiol. 2018;: pubmed publisher
    ..94-4.24]; p?=?0.074) nor in the matched population (log-rank p?=?0.520; 39% vs. 31%, HR 95%CI 1.34 [0.55-3.28]; p?=?0.523). In patients with dLVEF undergoing TAVI, periprocedural pECMO support does not seem to improve patient outcome. ..
  4. Husser O, Kessler T, Burgdorf C, Templin C, Pellegrini C, Schneider S, et al. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation. Rev Esp Cardiol (Engl Ed). 2016;69:141-8 pubmed publisher
    ..We found a trend toward a higher rate of new-onset intraventricular conduction abnormalities with SAPIEN 3 compared with SAPIEN XT, although this did not result in a higher permanent pacemaker implantation rate. ..
  5. Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr N, et al. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience. JACC Cardiovasc Interv. 2015;8:1809-16 pubmed publisher
    ..The S3 THV is associated with high procedural success and favorable early safety profile. The need for pacemaker implantations appears to be more frequent than with its predecessor. ..
  6. Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr N, et al. Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve. JACC Cardiovasc Interv. 2016;9:244-254 pubmed publisher
    ..056]; p = 0.003 per ms). Implantation depth and prosthesis oversizing were associated with a higher rate of new CA or PPI using the SAPIEN 3. Thus, avoidance of deep implantation and extreme oversizing may reduce these complications. ..
  7. Husser O, Nunez J, Burgdorf C, Holzamer A, Templin C, Kessler T, et al. Improvement in Risk Stratification in Transcatheter Aortic Valve Implantation Using a Combination of the Tumor Marker CA125 and the Logistic EuroSCORE. Rev Esp Cardiol (Engl Ed). 2017;70:186-193 pubmed publisher
    ..001). CA125 offers additional prognostic information beyond that obtained by the EuroSCORE. Elevation of both markers was associated with a poor prognosis. ..